Maximizing response to intratumoral immunotherapy in mice by tuning local retention.
Ontology highlight
ABSTRACT: Direct injection of therapies into tumors has emerged as an administration route capable of achieving high local drug exposure and strong anti-tumor response. A diverse array of immune agonists ranging in size and target are under development as local immunotherapies. However, due to the relatively recent adoption of intratumoral administration, the pharmacokinetics of locally-injected biologics remains poorly defined, limiting rational design of tumor-localized immunotherapies. Here we define a pharmacokinetic framework for biologics injected intratumorally that can predict tumor exposure and effectiveness. We find empirically and computationally that extending the tumor exposure of locally-injected interleukin-2 by increasing molecular size and/or improving matrix-targeting affinity impr
SUBMITTER: Momin N
PROVIDER: S-EPMC8748612 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA